197 related articles for article (PubMed ID: 32749203)
21. Textural features of dynamic contrast-enhanced MRI derived model-free and model-based parameter maps in glioma grading.
Xie T; Chen X; Fang J; Kang H; Xue W; Tong H; Cao P; Wang S; Yang Y; Zhang W
J Magn Reson Imaging; 2018 Apr; 47(4):1099-1111. PubMed ID: 28845594
[TBL] [Abstract][Full Text] [Related]
22. Prognostication of anaplastic astrocytoma patients: application of contrast leakage information of dynamic susceptibility contrast-enhanced MRI and dynamic contrast-enhanced MRI.
Kim HS; Kwon SL; Choi SH; Hwang I; Kim TM; Park CK; Park SH; Won JK; Kim IH; Lee ST
Eur Radiol; 2020 Apr; 30(4):2171-2181. PubMed ID: 31953664
[TBL] [Abstract][Full Text] [Related]
23. Relative sensitivities of DCE-MRI pharmacokinetic parameters to arterial input function (AIF) scaling.
Li X; Cai Y; Moloney B; Chen Y; Huang W; Woods M; Coakley FV; Rooney WD; Garzotto MG; Springer CS
J Magn Reson; 2016 Aug; 269():104-112. PubMed ID: 27288764
[TBL] [Abstract][Full Text] [Related]
24. Optimization of two-compartment-exchange-model analysis for dynamic contrast-enhanced mri incorporating bolus arrival time.
Nadav G; Liberman G; Artzi M; Kiryati N; Bashat DB
J Magn Reson Imaging; 2017 Jan; 45(1):237-249. PubMed ID: 27383624
[TBL] [Abstract][Full Text] [Related]
25. Impact of Arterial Input Function and Pharmacokinetic Models on DCE-MRI Biomarkers for Detection of Vascular Effect Induced by Stroma-Directed Drug in an Orthotopic Mouse Model of Pancreatic Cancer.
Cao J; Pickup S; Rosen M; Zhou R
Mol Imaging Biol; 2023 Aug; 25(4):638-647. PubMed ID: 37166575
[TBL] [Abstract][Full Text] [Related]
26. Prospective comparative diagnostic accuracy evaluation of dynamic contrast-enhanced (DCE) vs. dynamic susceptibility contrast (DSC) MR perfusion in differentiating tumor recurrence from radiation necrosis in treated high-grade gliomas.
Zakhari N; Taccone MS; Torres CH; Chakraborty S; Sinclair J; Woulfe J; Jansen GH; Cron GO; Thornhill RE; McInnes MDF; Nguyen TB
J Magn Reson Imaging; 2019 Aug; 50(2):573-582. PubMed ID: 30614146
[TBL] [Abstract][Full Text] [Related]
27. Assessing the reproducibility of high temporal and spatial resolution dynamic contrast-enhanced magnetic resonance imaging in patients with gliomas.
Lim WH; Park JS; Park J; Choi SH
Sci Rep; 2021 Dec; 11(1):23217. PubMed ID: 34853347
[TBL] [Abstract][Full Text] [Related]
28. Subcompartmentalization of extracellular extravascular space (EES) into permeability and leaky space with local arterial input function (AIF) results in improved discrimination between high- and low-grade glioma using dynamic contrast-enhanced (DCE) MRI.
Sahoo P; Rathore RK; Awasthi R; Roy B; Verma S; Rathore D; Behari S; Husain M; Husain N; Pandey CM; Mohakud S; Gupta RK
J Magn Reson Imaging; 2013 Sep; 38(3):677-88. PubMed ID: 23390002
[TBL] [Abstract][Full Text] [Related]
29. Influence of Different Measurement Methods of Arterial Input Function on Quantitative Dynamic Contrast-Enhanced MRI Parameters in Head and Neck Cancer.
Dong W; Volk A; Djaroum M; Girot C; Balleyguier C; Lebon V; Garcia G; Ammari S; Temam S; Gorphe P; Wei L; Pitre-Champagnat S; Lassau N; Bidault F
J Magn Reson Imaging; 2023 Jul; 58(1):122-132. PubMed ID: 36269053
[TBL] [Abstract][Full Text] [Related]
30. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2016 Mar; 2(1):56-66. PubMed ID: 27200418
[TBL] [Abstract][Full Text] [Related]
31. Diagnosis of Spinal Lesions Using Heuristic and Pharmacokinetic Parameters Measured by Dynamic Contrast-Enhanced MRI.
Lang N; Yuan H; Yu HJ; Su MY
Acad Radiol; 2017 Jul; 24(7):867-875. PubMed ID: 28162875
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetic modeling of dynamic contrast-enhanced MRI using a reference region and input function tail.
Ahmed Z; Levesque IR
Magn Reson Med; 2020 Jan; 83(1):286-298. PubMed ID: 31393033
[TBL] [Abstract][Full Text] [Related]
33. A novel AIF tracking method and comparison of DCE-MRI parameters using individual and population-based AIFs in human breast cancer.
Li X; Welch EB; Arlinghaus LR; Chakravarthy AB; Xu L; Farley J; Loveless ME; Mayer IA; Kelley MC; Meszoely IM; Means-Powell JA; Abramson VG; Grau AM; Gore JC; Yankeelov TE
Phys Med Biol; 2011 Sep; 56(17):5753-69. PubMed ID: 21841212
[TBL] [Abstract][Full Text] [Related]
34. A model-constrained Monte Carlo method for blind arterial input function estimation in dynamic contrast-enhanced MRI: II. In vivo results.
Schabel MC; DiBella EV; Jensen RL; Salzman KL
Phys Med Biol; 2010 Aug; 55(16):4807-23. PubMed ID: 20679695
[TBL] [Abstract][Full Text] [Related]
35. Operator dependency of arterial input function in dynamic contrast-enhanced MRI.
Kleppestø M; Bjørnerud A; Groote IR; Kim M; Vardal J; Larsson C
MAGMA; 2022 Feb; 35(1):105-112. PubMed ID: 34213687
[TBL] [Abstract][Full Text] [Related]
36. Estimating the arterial input function from dynamic contrast-enhanced MRI data with compensation for flow enhancement (II): Applications in spine diagnostics and assessment of crohn's disease.
van Schie JJN; Lavini C; van Vliet LJ; Kramer G; Pieters-van den Bos I; Marcus JT; Stoker J; Vos FM
J Magn Reson Imaging; 2018 May; 47(5):1197-1204. PubMed ID: 29193469
[TBL] [Abstract][Full Text] [Related]
37. Assessment of liver fibrosis using pharmacokinetic parameters of dynamic contrast-enhanced magnetic resonance imaging.
Li Z; Sun J; Chen L; Huang N; Hu P; Hu X; Han G; Zhou Y; Bai W; Niu T; Yang X
J Magn Reson Imaging; 2016 Jul; 44(1):98-104. PubMed ID: 26707910
[TBL] [Abstract][Full Text] [Related]
38. The Impact of Arterial Input Function Determination Variations on Prostate Dynamic Contrast-Enhanced Magnetic Resonance Imaging Pharmacokinetic Modeling: A Multicenter Data Analysis Challenge, Part II.
Huang W; Chen Y; Fedorov A; Li X; Jajamovich GH; Malyarenko DI; Aryal MP; LaViolette PS; Oborski MJ; O'Sullivan F; Abramson RG; Jafari-Khouzani K; Afzal A; Tudorica A; Moloney B; Gupta SN; Besa C; Kalpathy-Cramer J; Mountz JM; Laymon CM; Muzi M; Kinahan PE; Schmainda K; Cao Y; Chenevert TL; Taouli B; Yankeelov TE; Fennessy F; Li X
Tomography; 2019 Mar; 5(1):99-109. PubMed ID: 30854447
[TBL] [Abstract][Full Text] [Related]
39. Correlation of Tumor Immunohistochemistry with Dynamic Contrast-Enhanced and DSC-MRI Parameters in Patients with Gliomas.
Nguyen TB; Cron GO; Bezzina K; Perdrizet K; Torres CH; Chakraborty S; Woulfe J; Jansen GH; Thornhill RE; Zanette B; Cameron IG
AJNR Am J Neuroradiol; 2016 Dec; 37(12):2217-2223. PubMed ID: 27585700
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic Values of DCE-MRI and DSC-MRI for Differentiation Between High-grade and Low-grade Gliomas: A Comprehensive Meta-analysis.
Liang J; Liu D; Gao P; Zhang D; Chen H; Shi C; Luo L
Acad Radiol; 2018 Mar; 25(3):338-348. PubMed ID: 29223713
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
